It’s been a year of putting patient centricity theory into practice, as companies and industry organisations alike have shared their advice and embraced emerging technologies.
Patients increasingly want to be more involved in their healthcare, decisions about it and research towards its improvement, and there are some shining examples of patients moving front and
We speak to Keena Patel, a managing director in Accenture’s Life Sciences practice, about how pharmaceutical companies can improve their game in patient engagement.
Public and patient involvement (PPI) in clinical research is the new normal, but bridging the gap between how industry and charities work isn’t always easy.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.